FE Exclusive | India is a priority market; We aim to launch tirzepatide for obesity in India by 2025: Prof Rachel Batterham, Senior VP, International Medical Affairs, Eli Lilly
- Posted on November 24, 2024
- By Financial Express
- 1 Views
FE Exclusive | India is a priority market; We aim to launch tirzepatide for obesity in India by 2025: Prof Rachel Batterham, Senior VP, International Medical Affairs, Eli Lilly
Obesity is a chronic, progressive disease that can lead to serious health complications, reduced quality of life, and premature death, Prof Rachel Batterham told Financial Express.com.
